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Abstract
Engineering the physical properties of particles, especially their size, is an important parameter in
the fabrication of successful carrier systems for the delivery of therapeutics. Here, various routes
were explored for the fabrication of particles in the nanosize regime. It was demonstrated that the
use of a charged species and/or solvent with high dielectric constant can influence the size and dis-
tribution of particles, with the charged species having a greater effect on the size of the particles
and the solvent a greater effect on the distribution of the particles. In addition to the fabrication of
nanoparticles, their fractionation into specific size ranges using centrifugation was also investi-
gated. The in vitro particle uptake and intracellular transport of these nanoparticles was studied as
a function of size and incubation period. The highest level of intralysosomal localization was
observed for the smallest nanoparticle group (average of 174 nm), followed by the groups with
increasing sizes (averages of 378 and 575 nm), most likely due to the faster endosomal uptake of
smaller particles. In addition, the internalization of nanoparticle clusters and number of nanopar-
ticles per cell increased with longer incubation periods. This work establishes a technological
approach to compartmentalized nanoparticles with defined sizes. This is especially important as rel-
atively subtle differences in size can modulate cell uptake and determine intercellular fate. Future
work will need to address the role of specific targeting ligands on cellular uptake and intracellular
transport of compartmentalized nanoparticles.
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1 | INTRODUCTION
During the last decades, the use of carrier systems for the delivery of
therapeutics to specific locations in the body has gained significant
momentum. Nanoparticle-based delivery systems have evolved from
simple, nontargeted drug carriers to highly multifunctional systems with
various targeting, stealth, and delivery capabilities.1–3 There is evidence
that the physical properties of a carrier system, such as size and shape,
are as effective in determining the fate of the particles in the body as
the chemical properties of the particles, such as targeting and stealth
ligands incorporated on their surfaces.4,5 Specifically, the size of a car-
rier system can influence the therapeutic loading percentages, the
mode of delivery, induced toxicity levels, the circulation time in the
body, the carrier’s biodistribution in distinct organs, cellular uptake
routes, and clearance mechanisms from the body.4–8 For example,
while nanoparticles smaller than 100 nm can be taken up via clathrin-
mediated or caveolae-mediated endocytosis, nanoparticles between
500 nm and 5 lm are taken up via phagocytosis,5,9 although often sev-
eral routes of uptake are possible.10 Furthermore, nanoparticles smaller
than 8 nm are typically cleared via excretion through the kidneys, nano-
particles between 20 and 150 nm in size are cleared by the liver, and
larger than 200 nm nanoparticles are cleared by the spleen.5,11 Still,
these number should be taken as indicators of orders of magnitude,
rather that strict values as other factors also influence clearance. As
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such, the fabrication of nanoparticles in the nanosize regime and the
engineering of their specific sizes and distributions is a significant factor
is determining the effectiveness of a carrier system in the body.
A multitude of fabrication methods for the creation of polymeric
microparticles and microparticle exists, including various emulsion
methods,12 particle fabrication in nonwetting templates (PRINT) tech-
nology,13 self-assembly of block copolymers,14 electrospray techni-
ques,15,16 microfluidics,17 and layer-by-layer assemblies.18 Alternatively,
electrohydrodynamic (EHD) co-jetting has been developed as a high
throughput system for the fabrication of multifunctional particles and
fibers, where the internal architecture can be designed to incorporate
unique capabilities.19–21 During the EHD co-jetting process, two or
more polymeric solutions are flown in a side-by-side configuration
under a laminar regime, meaning that convective mixing is minimized,
and a stable interface between the fluids is achieved in the formed
droplet where the two solutions meet. Upon the addition of an electric
field, the droplet forms into a Taylor cone, and an electrified polymeric
jet is ejected from the very tip that forms into individual droplets. Due
to the rapid acceleration of the jet, the immediate reduction in diame-
ter, and the resulting increase in the surface area to volume ratio, the
solvents present in the droplets evaporate rapidly, leaving behind solidi-
fied particles. As a result of the rapid evaporation of the solvents and
the laminar flow regime, the initial flow determined configuration is
maintained in the particles in the form of distinct compartments.21
In the past decade, the fabrication of multicompartmental fibers and
particles with two to seven different compartments and with various
shapes via EHD co-jetting has been well-established.22–26 Additionally,
within these systems, the incorporation of water-based and organic-
based polymers,25,27–29 functional polymers for the creation of specific
targeting and stealth patches on the surface of the particles,30,31 stimuli-
responsive polymers for on-demand therapeutic release kinetics,32–34
small molecule-based therapeutics,33–35 DNA-based therapeutics,36
protein-based therapeutics,35 and imaging agents22 have been explored.
Furthermore, the interaction of such systems with various cell
types,34,36–41 their biodistribution in vivo,42 and their functionality as car-
riers for dual therapeutic delivery to the cochlea35,43 have demonstrated
that multifunctional systems fabricated based on EHD co-jetting can be
ideal carriers for targeted delivery in various applications. To date, the
majority of these studies have been accomplished using microparticles,
and while some have contained nanoparticles,36,37,42 a systematic study
into the fabrication of uniform, multifunctional nanoparticles using the
EHD co-jetting system has not been reported. In this manuscript, the
engineering of nanoparticles with specific size distributions via two dif-
ferent approaches, using charged species or specific solvents, is explored.
Upon confirmation of a systematic method for the fabrication of uni-
formly distributed nanoparticles at specific size ranges, their in vitro
uptake as a function of size and incubation period is examined.
2 | MATERIALS AND METHODS
2.1 | Materials for particle fabrication
Chloroform, dimethylformamide (DMF), phosphate buffered saline
(PBS), cetyl trimethylammonium bromide (CTAB), poly[tris(2,5-bis
(hexyloxy)21,4-henylenevinylene)-alt-(1,3- phenylenevinylene)] (PTDPV),
and tween 20 were used as purchased from Sigma-Aldrich, USA. Polylac-
tide-co-glycolide (Purasorb PDLG 5002A) with a ratio of 50:50 lactide to
glycolide and a molecular weight of 17 kDa was purchased from Cor-
bion, Inc., USA, and Polylactide-co-glycolide with a ratio of 50:50 lactide
to glycolide and a molecular weight of 17 kDa was purchased from Lake-
shore Biomaterials, USA.
2.2 | Particle fabrication
Particles were fabricated using the EHD jetting procedure. Briefly, the
17 kDa PLGA was dissolved at a 10% wt/vol concentration in various
ratios of chloroform and DMF, before being flown in a laminar regime
through parallel metallic needles at 0.1 ml per hour. For samples con-
taining CTAB, the charged surfactant was added directly to the polymer
solution. Upon the formation of a stable droplet at the interface of the
two polymeric solutions, a voltage was applied to the droplet creating a
polymeric jet from the tip of the needles. The polymeric jet then split
into individual droplets, causing the solvents to evaporate rapidly, leav-
ing behind solidified particles on the grounded electrode. To label the
nanoparticles with a fluorescent dye, an organic soluble fluorescent
polymer (PTDPV) was dissolved in the particle jetting solution at a
0.1 mg/ml concentration. The particles were then fabricated using the
EHD jetting system as described above, as the dye did not require any
additional changes to the jetting setup and postprocessing steps. This
dye was used due to its strong fluorescent activity (peaking at 518 nm
in its emission spectra, similar to fluorescein-based dye molecules), its
hydrophobic nature (chloroform solubility and water insolubility), and
its high molecular weight (Mw532 kDa), which together prohibited the
release of the dye from the nanoparticles during postprocessing steps
and further experiments. Once fabricated, the particles were imaged
via Scanning Electron Microscopy (SEM) to determine their shape and
size distribution. To quantify the size of the nanoparticles, the ImageJ
program was used to measure the size and distribution of over 500
nanoparticles per sample.
2.3 | Isolation of nanoparticles via centrifugation
Nanoparticles with a solvent ratio of 97:03 chloroform: DMF and 5%
wt/vol CTAB were fabricated and collected in PBS and 0.01% tween
20 (vol/vol). The particles were filtered using 40-lm Falcon cell
strainers, sonicated on ice, and centrifuged at 4,000 RPM for 5 min to
remove larger impurities. The resulting supernatants were spun at
10,000 RPM for 1, 5, 10, 20, and 30 min time intervals to isolate indi-
vidual size ranges of nanoparticles. The nanoparticles were character-
ized by Dynamic Light Scattering (DLS) to determine their size
distribution and Nanosight Nanoparticles Tracking Analysis (NTA) to
determine their concentration (particles per milliliter).
2.4 | Materials for cellular uptake studies
Sodium chloride and bovine serum albumin were purchased from Roth
and Jackson ImmunoResearch, UK, respectively. Resazurin solution (ala-
mar blue), DyLight 649 donkey anti-mouse IgG (H1L, secondary
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antibody), Phalloidin–tetramethylrhodamine B (phalloidin-TMR), and
saponin from quillaja bark (10%) were purchased from Sigma-Aldrich,
Germany. The 96-well assay plates from Corning, Germany, were used
for studying the cellular viability. Human cervical carcinoma (immortal-
ized from patient Henrietta Lacks, hence labeled “HeLa”) cells were pur-
chased from American Type Culture Collection, USA, and were seeded
in cell culture flasks (25, 75, 150 cm2) from Techno Plastic Products,
Germany. For cell counting, a Neubauer improved counting chamber
(hemocytometer) provided by MARIENFELD Laboratory, Germany,
glassware was used. PBS, paraformaldehyde (8%), Hoechst, trihydro-
chloride, trihydrate, and fluoromount-G were purchased from Biochrom
(Germany), Electron Microscopy Sciences, Life Technologies, and
Southern Biotech (Germany), respectively. Lysosomal-associated mem-
brane protein 1 (LAMP 1; mouse anti-human IgG1; developmental
studies hybridoma bank, Supernatant) was purchased from the Univer-
sity of Iowa, Department of Biology. Glycine (99%), sterilized 10-mm
round cover slips with thickness of 0.1760.005 mm, glass slides (76 3
26 mm), and parafilm were purchased from Carl Roth, Germany. The 4-
well tissue culture plates were obtained from Thermo Scientific,
Germany.
2.5 | Nanoparticle stability studies
The colloidal stability of nanoparticles of different average diameters
(d15174 nm, d25378 nm, and d35575 nm, as determined by DLS)
was studied44 in the presence of different concentrations of sodium
chloride and bovine serum albumin. The variation in the hydrodynamic
diameters (dh) of nanoparticles was used as an indicator of their stability
in saline and protein rich environments, respectively.45 Nanoparticles
were exposed to varying concentrations of sodium chloride in water
(0–5 M) and bovine serum albumin in PBS (0–800 mM). Final concen-
trations of nanoparticles after mixing with different concentrations of
NaCl and BSA were 2 3 109; and 4 3 10
9 nanoparticles/ml, respec-
tively. The hydrodynamic diameters of the nanoparticles were meas-
ured three times via DLS analysis and are presented with
corresponding standard deviations in Supporting Information Figure 1.
2.6 | Cellular toxicity studies
For determining the acute impact of the exposure of nanoparticles on
cellular viability, a resazurin-based cytotoxicity assay was performed,
which is based on the mitochondrial activity of the living cells.46,47
Active mitochondria of the living cells perform the bioreduction of the
dye, that is, they convert the nonfluorescent blue dye (resazurin) into
its reduced form (resorufin) which fluoresces pink. These studies were
performed by seeding HeLa cells in 96-well transparent bottom plates
(7,500 cells/well, area of each well was 0.32 cm2) in 100 ml of complete
growth media (Dulbecco's Modified Eagle Medium (DMEM) supple-
mental with 10% FBS, 1% P/S, and 1% glutaMAXTM) and incubated for
24 hr at 378C with a constant supply of 5% CO2. After 24 hr, when
HeLa cells had adhered to the bottom of 96-well assay plates, the old
growth media was replaced by fresh growth media containing nanopar-
ticles at different concentrations c(NP). Serial dilutions of nanoparticles
were performed to examine the toxic effect for a range of nanoparticle
concentrations (1 3 101021 3 107 nanoparticles/ml) and each dose was
added in triplicate. In a few wells of the assay plates, fresh growth media
(without nanoparticles) was added to the cells, which served as positive
control. After 24 hr of incubation of the cells with the nanoparticles, the
growth media was aspirated and the cells were washed with PBS fol-
lowed by the addition of 100 ml of 10% resazurin solution in complete
cell growth media into each well of the assay plates. Resazurin solution
(10%) was added in three wells of the assay plates (without cells), which
served as negative control and the assay plates were incubated for 3.5
hr under the aforementioned conditions. After 3.5 hr of incubation, the
fluorescence spectra of each well of the assay plates were recorded via
spectrofluorometer coupled with a microwell-plate reader using an exci-
tation wavelength of 560 nm and acquiring the emission spectra from
572 to 650 nm. The mean of the maximum fluorescence intensity values
for each concentration was determined and the viability for each nano-
particle concentration-treated cell was defined as the mean of the maxi-
mum fluorescence intensity of resorufin (originating from each well of
the assay plate). For background correction, the mean of background
values was subtracted from the mean of maximum fluorescence
intensity values for each concentration. Finally, all values obtained
were normalized with respect to their positive controls (cells without
nanoparticles).
2.7 | Cellular uptake of nanoparticles
HeLa cells were initially grown in 75 cm3 flasks and were seeded for
nanoparticle uptake on sterilized round glass cover slips
(diameter510 mm) placed into 4-well cell culture plates at a density of
20,000 cells per well. Each well had a surface area of 1.9 cm2 and was
filled with 0.5 ml of complete cell growth medium (DMEM supple-
mented with 10% FBS, 1% Glutamax, and 1% P/S). Cells were grown at
378C in an incubator with a constant supply of 5% CO2. After 24 hr,
the growth media was replaced by fresh growth media containing
nanoparticles at a final concentration of 1.5 3 108 nanoparticles/ml.
Nanoparticles were shortly sonicated for 30 s just before mixing with
cell growth medium and cells were exposed to nanoparticles for differ-
ent time intervals (6, 12, and 24 hr) under the aforementioned condi-
tions. In parallel, control experiments were also performed in which
cells were grown in the presence of complete cell growth media with-
out addition of nanoparticles.
After incubation with nanoparticles for defined time intervals, the
cells were washed with PBS and fixed with 4% paraformaldehyde solu-
tion in PBS (20 min incubation at room temperature), followed by three
washes with PBS. The fixed cells were transferred on Parafilm previ-
ously spread on an unmodified surface and were exposed to permeabil-
ization solution (glycin 5 mg/ml and saponin 0.5 mg/ml, in PBS) for 5
min at room temperature, followed by treatment with blocking solution
(20 mg/ml BSA in the permeabilization solution) for 30 min at 378C.
Cells with nanoparticles were immunostained by means of LAMP 1
(2 mg/ml, primary antibody in blocking solution), incubated for 1 hr at
378C, washed three times with blocking solution and exposed to a solu-
tion of Dylight 649 conjugated donkey anti-mouse (1.25 mg/ml,
84 | RAHMANI ET AL.
secondary antibody), Hoechst 33342 (0.5 mg/ml), and phalloidin-TMR
(40 nM) in PBS for another 1 hr at 378C. Hoechst 33342 and
phalloidin-TMR were used to stain cellular nuclei and cytoskeletons,
respectively.10,48 Afterward, the cells were washed three times with
PBS, one time with water and after mounting with Fluoromont-G
on glass slides (76 3 26 mm) were placed in a dark and dry place
for 24 hr.
A Confocal Laser ScanningMicroscope (CLSM 510Meta) from Zeiss
was used for visualizing the fixed and immunostained cellular samples
containing internalized nanoparticles. For sample visualization and image
acquisition, the CLSMwas equipped with diode, argon, and helium neon
lasers and excitations of 405, 488, 543, and 633 nm were used for all
imaging. Fluorescence micrographs of immunostained samples with
internalized nanoparticles and their corresponding controls (cells without
nanoparticles) were captured. The nuclei stained with Hoechst reagent
were excited at 405 nm and the dye emission was detected between
420 and 480 nm. Nanoparticles containing the PTDVP dye were visual-
ized by exciting at 488 nm and detecting the emission between 505 and
550 nm. The fluorescence of the phalloidin-TMR labeled cytoskeleton
was excited at 543 nm, and emission was captured using a 560-nm long
pass filter. Antibody-labeled lysosomeswere excited at 633 nm, and their
emissionwas recorded via a 650-nm long pass filter.
In detail, z-stacks/three-dimensional (3D) image stacks (with 0.1
mm resolution in the xy-plane and 0.48 mm resolution along the z axis)
were acquired using a pinhole aperture of 1 Airy unit. Thirty to fifty
images were recorded per sample covering an average of 60–100 cells
per condition. Images of control samples were acquired to set threshold
values for image processing and data evaluation of nanoparticle-treated
samples. To assess the number and intracellular location of internalized
nanoparticles from fluorescence image stacks a similar procedure was
applied as proposed by Torrano et al.49,50
The uptake of nanoparticles by cells, in particular their intralyso-
somal fraction, was quantified by Digital Image Cytometry51,52 using
the fluorescence micrographs captured by CLSM.48 Each cell (includ-
ing the nucleus, lysosomes, and associated nanoparticles) was recon-
structed and modeled in 3D using MATLAB (Mathworks) and
CellProfiler53 by applying the following approach: based on the two-
dimensional (2D) plane (around z50 mm) where cells showed the
largest cross-sectional area, the outlines of the individual cells were
identified as described by Pelaz et al.54 These outlines were
expanded along the z-dimension to separate touching cells reliably
by die-cutting the reconstructed volumetric data at a later stage.
Prior to modeling, the images in different fluorescence channels of
the stack underwent noise reduction by 3D-median filtering with a
FIGURE 1 Using the same polymer and concentration, particles ranging in diameter (d) from micrometers (A) to nanometers (D) were pre-
pared. By increasing the amount of DMF, polydisperse microparticles (A) could be downsized to bimodal particles where one set was at
approximately 1 lm and one at 100 nm (B). Alternatively, by adding a charged surfactant, polydispersed microparticles (A) could be down-
sized to polydispersed nanoparticles ranging in size from 50 to 800 nm (C). Combining these effects resulted in monodispersed nanoparticles
in the 50–150 nm range (D). The insets in each image represent a higher magnification image of the particles (top) and the size distribution
of the particles based on ImageJ analysis of SEM images (bottom)
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kernel size of 3 3 3 3 3 voxels. In case of nuclei and cytoskeletal
signals, the images were slightly smoothed after noise reduction
with a 3D Gaussian filter of size 5 3 5 3 3 pixels. Then, all slices
were binarized by manual thresholding. Following this, morphologi-
cal operations were applied to improve the quality of the 3D recon-
struction (cleaning the image stack from very small clusters
consisting of less than 4 3 4 3 4 connected voxels and filling holes in
the remaining structures). In case of the cytoskeletal stain, the images
were morphologically closed with a three-voxel-sized diamond-shaped
structuring element after binarization to avoid ruptures in the recon-
structed cell surface. The images of the channel containing the nano-
particle signals were treated exactly as described earlier. Finally, all
connected voxels were identified yielding a volumetric representation
of nuclei, cells, lysosomes, and aggregates of nanoparticles.
For each aggregate of nanoparticles (in terms of connected voxels),
the total integrated fluorescence intensity was determined (to calculate
the amount of nanoparticles per aggregate) and the relative position
with respect to the cell and lysosomal structures was calculated. Nano-
particle aggregates located in the extracellular areas were not consid-
ered (ie, center of mass of aggregate was outside the cell body volume).
Nanoparticles overlapping with lysosomal structures (ie, the center of
mass of the aggregate of nanoparticles was inside the lysosomal vol-
ume) were classified as being located inside the lysosomes. Based on
these assumptions the number of nanoparticles per cell, Ncell, and the
fraction localized inside the lysosomes, Nlyso, was calculated. The inter-
nalization results are expressed as median values6upper/lower quar-
tile. However, larger particles (clusters/clumps of nanoparticles) with
high fluorescence intensity were also detected while quantifying the
internalization of nanoparticles, the presence of which might hamper
the precision of the evaluated data.
3 | RESULTS AND DISCUSSIONS
Size is an important physical parameter for particles used in drug deliv-
ery applications due to its influence over circulation times, rates of
opsonization, cellular uptake, passive targeting to tumors via the EPR
effect, tumor penetration, and excretion from the body.55,56 In the
EHD co-jetting system, several parameters such as polymer molecular
weight and concentration, solvent viscosity and dielectric constant, and
the applied voltage mainly control the size and uniformity of particles
ranging from micrometer to nanometer in diameter. One of the most
common routes of fabricating nanoparticles and nanofibers via electro-
spraying, is the use of polymeric solutions with dilute
concentrations.57–60 Based on this, our initial studies on the fabrication
of nanoparticles focused on the use of polymers with low molecular
weight values (4.1 kDa) and at dilute concentrations (0.01–1% wt/vol).
While these experiments did result in nanoparticles as small as 100–
200 nm (Supporting Information Figure 1), the yield was extremely low
FIGURE 2 Effect of CTAB concentration on the diameter (d) and distribution of nanoparticles when the polymer concentration and solvent
ratios are kept constant. (A) Box plot of nanoparticle size distributions, and (B–L) are representative SEM images of particles with 0–10%
wt/vol of CTAB, respectively
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for this process due to the dilute concentrations used (as a reference,
the images shown in Supporting Information Figure 1 were taken after
4–10 hr of jetting on the same substrate (S. F. 1 A-C, respectively),
where for all images shown in Figures 1–3, the jetting was only done
for 30 min). As a result, other routes of fabricating nanoparticles were
explored to establish a fabrication procedure that could result in higher
yields.
The other common parameters investigated for the fabrication of
nanoparticles include the use of solvents with higher dielectric constants/
surface tensions and the incorporation of charged species, which affect
the overall charge of the jetting solutions. It has been well established that
the use of solvents with high dielectric constants, such as N, N-dimethyl
formamide (DMF), can result in the fabrication of nanofibers rather than
microfibers due to the induced higher net charge density on the jetting
solution.61–63 Similarly, the use of a charged surfactant results in an overall
increase in the charge density and conductivity of the jetting solution,
which ultimately results in nanofibers and particles with smaller diame-
ters.15,62,64,65 Building on these studies, the effect of each parameter,
using the same poly (lactide-co-glycolide) polymer (PLGA 50:50, 17 kDa)
and at the same concentration of 10% wt/vol, on particle size and their
combined effects were subsequently studied. It was observed that a sol-
vent ratio of 97:03, chloroform:DMF yielded polydispersed microparticles
(Figure 1A), while the same solution with a solvent ratio of 1:1, chloro-
form:DMF yielded bimodal, yet uniform particles with one set of nanopar-
ticles at approximately 50–150 nm and a second set at approximately
1 lm (Figure 1B). Alternatively, keeping the same ratio of solvents (97:03),
but adding a charged surfactant, CTAB, at 5% wt/vol resulted in a polydis-
persed population of nanoparticles ranging from 50 to 800 nm (Figure
1C). Combining these two parameters (5% wt/vol CTAB addition and a
ratio of 1:1 chloroform: DMF) resulted in monodispersed nanoparticles
ranging from 50 to 150 nm in diameter (Figure 1D). Higher magnification
images and the size distribution of the nanoparticles based on ImageJ anal-
ysis of the SEM images are included as insets for each set of particles.
To fully understand the effect of each of these parameters
(charged species and solvent with higher dielectric constant), a more
systematic study was conducted, where each parameter was tested at
an increasing concentration or ratio, while keeping all other parameters
constant. To study the effect of the charged species, the concentration
of the CTAB was increased from 0 to 10% wt/vol at 1% intervals, while
the polymer concentration, molecular weight, and solvent ratio (97:03
Chloroform:DMF) were kept constant in order to isolate the effect of
the charged species.
The resulting particles were imaged with SEM and their size
distribution was determined based on analysis with the program
ImageJ. As demonstrated in Figure 2, the median values and the
size distributions for the nanoparticles decrease as the CTAB con-
centration is increased (the median value and size distribution of
the zero percent particles are not included in the graph due to the
much larger values of 3,255 nm and 450–16,710 nm, respectively).
However, there is a limit to the amount of CTAB that can be used
in a given solution: at higher values than 5% wt/vol, the jetting
solution results in the fabrication of a mixture of nanoparticles and
FIGURE 3 Effect of solvent ratio on the size (in terms of particle diameter d) and distribution of nanoparticles when the concentration of
the polymer and charged species are kept constant. (A) Box plot of nanoparticle size distributions and (B–G) are SEM images of nanopar-
ticles with a decreasing amount of chloroform to DMF ratio of 100:00 to 50:50, respectively
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fibers, instead of the desired smaller sized nanoparticles. Addition-
ally, the stability of the jetting solution and the yield of the nano-
particles also decreases with increasing CTAB concentrations. As a
result, the optimum formulation for fabricating nanoparticles by
solely relying on the effect of a charged species is approximately 4–
5% wt/vol. In addition, CTAB can be cytotoxic and thus its use at
high concentrations is not desirable.
A similar study was conducted to determine the optimum ratio of
chloroform to DMF for the engineering of uniform nanoparticles at spe-
cific size ranges. Here, the polymer concentration, molecular weight, and
CTAB concentration (5% wt/vol) were kept constant, while the ratio of
chloroform and DMF was decreased from 100:00 to 50:50, respectively
(Figure 3). Similar to nanoparticle formulations with higher than 5% wt/
vol of CTAB, the formulation with chloroform as the sole solvent
resulted in a sample with fibers and particles. For formulations with
DMF, nanoparticles without any fibers could be fabricated, which nar-
rowed in size as the ratio of chloroform to DMF was decreased. As dem-
onstrated in Figure 3, a distinct difference in size distribution can be
seen after the 80:20 chloroform to DMF ratio, where both the median
size and the distribution drops significantly. As a note, while not much
difference is observed in the median and distribution of the samples
with 30, 40, and 50% DMF ratios, the yield of the nanoparticles did
decrease with increasing DMF concentration. This is most likely due to
the insolubility of CTAB in DMF and the instability in the Taylor cone
associated with this. Thus, the samples with the higher yields and lowest
nanoparticle size and distribution were achieved with the 70:30 and
60:40 chloroform to DMF ratios. By employing DMF, a much more uni-
form population of nanoparticles as compared to the CTAB samples
could be engineered. As such, it would appear that while CTAB can be
used to reduce the size of the particles from micron-sized to nanosized,
the incorporation of higher DMF ratios can be used to engineer nano-
particles with more uniform size distributions.
In addition to fabricating monodispersed nanoparticles, the isolation
of nanoparticles with specific size ranges from a polydispersed sample
can be of interest, especially as it allows for the side-by-side testing of
nanoparticles with the same properties (same batch, material, and physi-
cal characteristics), but with different size ranges. This fractionation can
be achieved by using serial centrifugation (Figure 4A), where a polydis-
persed sample of particles (here the sample in Figure 1C) is centrifuged
at a set force of 9,400 relative centrifugal force for longer durations to
pellet increasingly smaller nanoparticles. The size distribution of several
fractions (1, 10, 20, and 30 min) with median sizes of 44, 122, 220, and
615 nm are shown in Figure 4B, as analyzed by DLS. In addition, a SEM
image of the 30 min sample showing nanoparticles with a size distribu-
tion of 30–110 nm is demonstrated as an inset in Figure 4C. Here, the
hydrodynamic diameter (dh) as measured by DLS is displayed as oppose
FIGURE 4 Separation of a polydispersed group of nanoparticles into monodispersed fractions using serial centrifugation. (A) Schematic dis-
playing serial centrifugation. (B) Size distribution (in terms of hydrdodynamic particle diameter (dh) of different fractions (1, 10, 20, and 30
min) based on DLS measurements. (C) Representative image of uniform 50-nm nanoparticles from the 30-min sample
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to the diameters shown in previous figures that were measured by
ImageJ analysis of SEM images (denoted as “d” in this manuscript).
As mentioned previously, the isolation of particles with specific size
ranges from the same batch of particles, rather than their individual fabri-
cation by changing the jetting parameters, allows for the side-by-side
study of their behavior solely as a function of size. Note that such fractio-
nation techniques can be very precise, allowing for the isolation of dis-
crete particle species.66 We were specifically interested in employing this
technique to study the effect of size on the cellular uptake of nanopar-
ticles. To begin, nanoparticles with average hydrodynamic diameters of
174, 378, and 575 nm were isolated via serial centrifugation and their
colloidal stability in buffered solutions containing various salt (sodium
chloride at 0–5 M) and protein (bovine serum albumin at 0–800 mM) con-
centrations were studied (Supporting Information Figure 2).44 The varia-
tion in the hydrodynamic diameter (dh) of the nanoparticles was analyzed
by DLS measurements and used as an indicator of their stability. While
the nanoparticles were stable in sodium chloride concentrations of less
than 0.34 M, at higher concentrations the size of the nanoparticles
increased as they started to aggregate in the solution. Such behavior is
well known for most colloids.67 However, as typical physiological concen-
trations of sodium chloride in the body are at 0.15 M, all three nanopar-
ticle samples are expected to be colloidally stable for drug delivery
applications as with regard to the salt concentrations.
Incubation studies with albumin were conducted to study the
effect of the creation of a protein corona on the stability of these nano-
particles in solution.45 The nanoparticles, especially the two larger sets
of nanoparticles, were shown to be relatively stable in increasing con-
centrations of the albumin and increased in size as the concentration of
albumin, and the size of the protein corona, increased. The effect of the
protein corona was more pronounced on the smaller nanoparticles as
the protein corona would be more obvious on the smaller sized par-
ticles (ie, a protein corona of 50 nm is more pronounced on 100 nm
particles [50% size increase] than on 500 nm particles [10% size
increase]). While the nanoparticles are prone to building a protein
corona, this can potentially be mitigated by incorporating stealth moi-
eties as surface modifications in future studies.
Before conducting in vitro studies to determine the effect of size on
nanoparticle uptake, the cytotoxicity of the nanoparticles was deter-
mined. A resazurin-based assay was used to demonstrate the cytotoxicity
by incubating known concentrations of nanoparticles (particles per millili-
ter as determined by Nanosight’s NTA technique) with HeLa cells. The
resazurin assay is based on the mitochondrial activity of living cells, where
the active mitochondria perform the reduction of the dye that can be
detected via a plate reader.46,47 In other words, the fluorescence intensity
of resorufin can be directly related to the viability of the cells. Note that
this test has to be regarded as a basic screening for the acute toxic
effects of nanoparticles on cells, whereas for more profound analysis
more sophisticated tests are necessary. In particular, due to the short
incubation times only severe acute reduction in cellular viability can be
probed. The viability studies were performed by seeding HeLa cells for
24 hr, followed by incubation with nanoparticles at various concentra-
tions (107 to 1010 nanoparticles per ml). After a 24-hr incubation, the res-
azurin assay determined the number of live cells as compared to controls
that were not incubated with nanoparticles. From these studies (Figure
5A), it was determined that none of the nanoparticle fractions imposed
acute cytotoxicity to HeLa cells at concentrations below 43 108 nano-
particles per ml. As such, nanoparticle uptake studies with the HeLa cells
were done at a concentration of 1.5 3 108 nanoparticles per ml, in order
to ensure that toxicity would not be a factor in the studies.
To study the cellular uptake of nanoparticles as a function of size,
the three separate nanoparticle populations (average hydrodynamic diam-
eters of 174, 378, and 575 nm) were incubated with HeLa cells for 6, 12,
and 24 hr. After the incubations, the cells were fixed, and their cytoskele-
ton, nuclei, and lysosomes were immunostained.10 The samples were
FIGURE 5 Cellular uptake of nanoparticles. (A) Cell viability (V) of HeLa cells upon 24 hr of exposure to nanoparticles as a function of
nanoparticle concentration c(NP). Data present the mean values of three experiments with corresponding standard deviations. (B) A repre-
sentative CLSM image of nanoparticles internalized by HeLa cells after 12 hr of incubation. Stained cellular compartments are shown as
phalloidin-TMR conjugated cytoskeleton (B.1, red), fluorescently labeled nanoparticles (B.2, green), Hoechst stained cellular nuclei (B.3, blue),
immunostained lysosome (B.4, yellow), and an overlay of all channels showing aforementioned cellular compartments and nanoparticles
(B.5). The scale bars correspond to 20 mm
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analyzed with confocal microscopy to view the uptake of the nanopar-
ticles as a function of size over time. An example of the 2D images
obtained from these studies is demonstrated in Figure 5B.1–5, where the
cytoskeleton (red), nanoparticles (green), nuclei (blue), lysosomes (yellow),
and their overlay image can be seen, respectively. Here, the 378 nm
nanoparticles were incubated for 12 hr with HeLa cells. Corresponding
control studies, where nanoparticles were not incubated with the cells,
were also done for later correlation studies to set the threshold values
for the image processing and data evaluation of the nanoparticle treated
cells (an example of these studies at the 12-hr incubation without nano-
particles is displayed in Supporting Information Figure 3).48
Additionally, images at different focal planes were also obtained
for each of the samples, which were then reconstructed into 3D images
as demonstrated in Figure 6. Here, the DLS data in Figures 6A.1, 6B.1,
and 6C.1 display the size distribution of each set of nanoparticles, fol-
lowed by the 3D reconstructed images of the cellular uptake of the
nanoparticles as a function of time (6, 12, and 24 hr). Similar to the 2D
images in Figure 5, here the nucleus (blue), cytoskeleton (red), lyso-
somes (yellow), and nanoparticles (green) are demonstrated. As can be
observed for all three size fractions, the number of nanoparticles asso-
ciated with cells increase as the duration of nanoparticle incubation
increases. Longer incubation time allows for a larger portion of the cells
to come into contact with the nanoparticles and permits multiple routes
of nanoparticle uptake to take place. This is especially important for the
larger sized nanoparticles, as their mode of uptake may be different
due to their larger size.5,9
To quantify this data and determine the absolute number of inter-
nalized fluorescent nanoparticles per cell, an average integrated
FIGURE 6 Cellular uptake of nanoparticles with different hydrodynamic diameter (dh) as a function of time. (A.1–C.1) Size distribution of
the nanoparticles and (A.2–C.4) nanoparticle uptake by cells after 6, 12, and 24 hr as demonstrated by 3D reconstructions of confocal
images, respectively. Here, the cytoskeleton (red), nuclei (blue), lysosomes (yellow), and nanoparticles (green) are demonstrated
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florescence signal per nanoparticle was determined for each nanopar-
ticle type.48 For this purpose, a z-stack of a drop of diluted nanoparticle
suspension was acquired and embedded in fluoromount-G to mimic
the conditions used for cell imaging, and to inhibit Brownian motion.
For determining the distribution of integrated fluorescence intensity
per nanoparticle, individual nanoparticles were segmented applying the
following procedure: (a) the photon shot noise was removed by 3D-
median filtering with a kernel size of 3 pixels, (b) the image was con-
verted by manually defining the threshold, and (c) the morphological
operations were applied to improve the quality of the 3D reconstruc-
tion. Finally, the connected components in the resulting matrix were
identified and the underlying fluorescence signal of each voxel cluster
(referring to one or more nanoparticles) was summed to determine the
distribution of the integrated intensity values per nanoparticle.48 The
maxima of the resulting distribution functions were picked as average
integrated intensity per nanoparticle (Supporting Information Figure 4).
Based on this information, and the obtained volumetric cell data
from confocal imaging, the total number of internalized nanoparticles
per cell could be calculated (Figure 7). Here, the volumetric cell data are
the number of nanoparticle clusters, which is proportional to the vol-
ume of incorporated nanoparticles, and the total number of internalized
nanoparticles is the volume of internalized nanoparticles divided by the
volume of one nanoparticle. As explained in the methods section, it
was automatically distinguished whether a nanoparticle was adhering
to the cellular plasma membrane or already fully internalized. Addition-
ally, the nanoparticles were correlated spatially with lysosomes for fur-
ther analysis. In general, greater enrichment of nanoparticles inside the
cells and lysosomes was observed with the passage of time as the
nanoparticles have more opportunity to come into contact with the
cells and be taken up (Figure 7A). Additionally, greater intralysosomal
localization of the nanoparticles with the smallest sized nanoparticle set
(average of 174 nm) was observed, followed by sets in increasing sizes
(averages of 378 and 575 nm), most likely due to the faster endosomal
uptake of smaller nanoparticles (Figure 7C). In addition, the internaliza-
tion of nanoparticle clusters and number of nanoparticles per cell were
the highest for the largest nanoparticle size. We note that for such
studies the metrics of uptake is paramount, which in this case was cho-
sen as the number of internalized nanoparticles per cell.68
FIGURE 7 Quantification of nanoparticle uptake by cells. The data are displayed for the number of nanoparticle clusters per cells (A), num-
ber of nanoparticles per cells (B), and 3D lysosomal overlap percentage (C)
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Nevertheless, the outcome is somewhat unexpected and future studies
will need to focus on addressing the underlying mechanism.
4 | CONCLUSIONS
The fabrication of nanoparticles and the engineering of their size and
distribution is an important factor in the design and success of carriers
for drug delivery applications. Here, the fabrication of nanoparticles via
the EHD co-jetting technique using three different strategies (low con-
centrations, solvent choice, and charged species) and their resulting
nanoparticles is explored. It is demonstrated that while using low con-
centrations of polymeric solutions can result in nanoparticles, the yields
are low. Alternatively, uniform nanoparticles with high yields can be
fabricated by the incorporation of a charged species, CTAB, and a sol-
vent with a high dielectric constant, DMF, which result in size reduction
and uniformity, respectively. Furthermore, a polydispersed population
of nanoparticles was fractionated into specific size ranges via serial cen-
trifugation to study their cellular uptake as a function of their size,
while keeping all other parameters constant. The uptake of the nano-
particles over time (6, 12, and 24 hr) and their association with lyso-
somes were investigated. Based on these studies, it is demonstrated
that uniform nanoparticles in high yields can be prepared based on the
EHD co-jetting technique and that such nanoparticles can be of value
for in vitro and in vivo studies for specific applications.
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